Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
MDM Policy & Practice|May 8, 2023
Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening ProgramStuart J Wright, Martin Eden, Helen Ruane, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2023
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceTommi Tervonen, Jorien Veldwijk, Katherine Payne, et al.
Circulation|June 23, 2017
Study Comparing Vein Integrity and Clinical Outcomes in Open Vein Harvesting and 2 Types of Endoscopic Vein Harvesting for Coronary Artery Bypass Grafting: The VICO Randomized Clinical Trial (Vein Integrity and Clinical Outcomes)Bhuvaneswari Krishnamoorthy, William R Critchley, Alexander J Thompson, et al.
BMJ Open|July 10, 2026
Clinical and cost-effectiveness of oral versus intramuscular glucocorticoids in rheumatoid arthritis: protocol for a multicentre randomised controlled trial with economic evaluation and qualitative sub-study (LEADER trial)Jonathan Alistair Cook, Nicky Wilson, Kate Wilkins, et al.
The British Journal of Ophthalmology|June 7, 2013
Understanding the expectations of patients with inherited retinal dystrophiesRyan Combs, Georgina Hall, Katherine Payne, et al.
The Journal of Investigative Dermatology|April 19, 2026
The role of biosimilars in enhancing global access to psoriasis treatmentYasmina Behlock, Sean P Gavan, Thomas Graier, et al.
European Journal of Human Genetics : EJHG|February 14, 2013
Understanding the impact of genetic testing for inherited retinal dystrophyRyan Combs, Marion McAllister, Katherine Payne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest groupEric Faulkner, Lieven Annemans, Lou Garrison, et al.
BMC Proceedings|October 24, 2024
Risk stratification in breast screening workshopAndrew Anderson, Cristina Visintin, Antonis Antoniou, et al.
The Lancet Regional Health. Europe|November 7, 2024
Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trialMike Slade, Stefan Rennick-Egglestone, Clare Robinson, et al.
Pageof 19